Pruritus Therapeutics Market By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Pipeline, Unmet Needs), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria) Report

Pruritus Therapeutics Market By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Pipeline, Unmet Needs), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria) Analysis And Segment Forecasts To 2025

  • Published Date: Mar, 2015
  • Base Year for Estimate: 2014
  • Report ID: 978-1-68038-365-2
  • Format: Electronic (PDF)
  • Historical Data: 2012-2014
  • Number of Pages: 78

Market segmentation 

  • Global Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    • Corticosteroids
    • Antihistamines
    • Local Anesthetics
    • Counterirritants
    • Immunosuppressant
    • Calcineurin Inhibitors
    • Others
  • Global Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    • Atopic Dermatitis
    • Allergic Contact Dermatitis
    • Urticaria
    • Others
  • Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2012 - 2025)
    • North America
      • U.S.
        • U.S. Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • U.S. Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
    • Rest of North America
      • Rest of North America Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
        • Corticosteroids
        • Antihistamines
        • Local Anesthetics
        • Counterirritants
        • Immunosuppressant
        • Calcineurin Inhibitors
        • Others
      • Rest of North America Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
        • Atopic Dermatitis
        • Allergic Contact Dermatitis
        • Urticaria
        • Others
    • Europe
      • Germany
        • Germany Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • Germany Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
      • UK
        • UK Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • UK Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
      • France
        • France Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • France Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
      • Italy
        • Italy Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • Italy Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
      • Spain
        • Spain Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • Spain Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
      • Rest of Europe
        • Rest of Europe Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • Rest of Europe Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
    • Asia Pacific
      • Japan
        • Japan Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • Japan Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
      • Rest of Asia Pacific
        • Rest of Asia Pacific Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
          • Corticosteroids
          • Antihistamines
          • Local Anesthetics
          • Counterirritants
          • Immunosuppressant
          • Calcineurin Inhibitors
          • Others
        • Rest of Asia Pacific Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
          • Atopic Dermatitis
          • Allergic Contact Dermatitis
          • Urticaria
          • Others
    • RoW
      • RoW Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
        • Corticosteroids
        • Antihistamines
        • Local Anesthetics
        • Counterirritants
        • Immunosuppressant
        • Calcineurin Inhibitors
        • Others
      • RoW Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
        • Atopic Dermatitis
        • Allergic Contact Dermatitis
        • Urticaria
        • Others

 

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

 Quantitative Analysis

  • Market size, estimates, and forecast from 2012 to 2025
  • Revenue estimates for product up to 2025
  • Regional market size and forecast for product up to 2025
  • Revenue estimates for disease type up to 2025
  • Regional market size and forecast for disease type up to 2020
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.